Conversely, it has been shown that aberrant extracellular expression of myeloperoxidase, as a constituent of neutrophil extracellular traps, may predispose to the development of anti-MPO antibodies,31 and that neutrophil extracellular traps are formed in experimental anti-GBM disease.32 The gene discussed is MPO; the disease is glioblastoma.